Sarissa Capital Management LP
Source: SEC Form 13F · as of Mar 2026Sarissa Capital Management LP holds 4 biotech & pharma companies tracked by BioSniper, totaling $72.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
4
Total value held
$72.7M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Innoviva, Inc. (INVA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| INVAInnoviva, Inc. | 2,130,950 | $49.7M |
| CYTKCYTOKINETICS INC | 228,623 | $15.1M |
| BHVNBiohaven Ltd. | 563,184 | $4.8M |
| REGNREGENERON PHARMACEUTICALS, INC. | 4,190 | $3.2M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.